Genomic Health, Inc.’s (GHDX) share price has entered into oversold territory with a stochastic value of 11.3322. The Zacks Consensus Estimate on the company’s earnings for year ending December 2012 increased by 2 cents over the past month to 18 cents per share. Genomic Health, Inc. is a Zacks #2 Rank (“Buy”) company.
GENOMIC HEALTH INC (GHDX): Free Stock Analysis Report
More From Zacks.com
The S&P 500 could bottom out in the next month, according to Fundstrat's head of research Tom Lee.
One of the fastest-growing utility stocks, along with "Wall Street's Greatest Dividend Stock," make for phenomenal buys right now.
Futures initially tumbled overnight, but slashed losses as Israel's attack on Iran seemed limited. The market power trend is about to end. Netflix gave weak guidance.
Trump Media is advising investors on ways to prevent their shares from being loaned for a short-interest position.
Wall Street's most-prominent stock-split stock of 2024 has been purchased on three separate occasions by a lawmaker who completed over 4,200 trades last year.
The adoption of AI is just getting started, offering astute investors the opportunity to profit from this step change in technology.
A measure of calm was returning after Israel's retaliatory strike on Iran spooked the market and spurred a rush to safe havens such as gold.
(Bloomberg) -- An escalation of tensions in the Middle East kept stock markets on edge, though haven assets including bonds and the dollar gave up some early gains after Iranian media appeared to downplay the impact of Israeli strikes.Most Read from BloombergElon Wants His Money BackDubai Grinds to Standstill as Flooding Hits CityIsrael Reported to Have Launched Retaliatory Strike on IranRecord Rainfall in Dubai? Blame Climate Change, Not Cloud SeedingOil Erases Advance After Iranian Media Downp
Artificial intelligence (AI) is the thread that unites this winning trio of technology stocks.
Tesla's growth story was about leading the paradigm shift to EVs, and an affordable car was a part of that story. Now without it, the narrative has changed.